Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited was incorporated in 1996 and it is a manufacturer of a diverse portfolio of structure Directing Agents, Phase Transfer Catalysts, electrolyte salts for batteries, and Pharmaceutical and Agrochemical Intermediates and other Speciality chemicals
What Tatva files
- Investor Meet54
- Others52
- Important15
- PPTs8
- Board Meeting8
- Dividend/Bonus4
Tatva Chintan Pharma Chem Limited has announced participation in a one-to-one virtual meeting with HSBC Securities and Capital Pvt. Ltd. Discussions will focus strictly on publicly available information, ensuring no confidential or unpublished price-sensitive information is shared during the interaction.
CRISIL Ratings has upgraded Tatva Chintan Pharma Chem Limited’s long-term bank facilities to CRISIL A-/Stable from CRISIL BBB+/Stable and short-term facilities to CRISIL A2+ from CRISIL A2, covering total bank loan facilities of Rs. 245 Crore.
Tatva Chintan Pharma Chem Limited has informed the Exchange about Copy of Newspaper Publication
Tatva Chintan has set **Friday, September 11, 2026**, as the Record Date. This is to determine shareholders eligible for the final dividend for FY 2025-26. The 30th Annual General Meeting (AGM) will be held on September 25, 2026. If approved at the AGM, the dividend payment will commence from October...
Tatva Chintan's FY25-26 report shows rising employee turnover and increased accounts payable days. Positively, the company expanded green investments, achieving zero liquid discharge in one unit, and continued robust export contribution at 75% of turnover. No fines or product recalls were reported.